prednisone has been researched along with Gastroesophageal Reflux in 15 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Gastroesophageal Reflux: Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Omeprazole is a drug widely used in the treatment of gastroesophageal reflux disease and peptic ulcer disease." | 8.82 | [Acute interstitial nephritis associated with omeprazole therapy]. ( Calvo, C; García, H; Hernández-Jaras, J; Maduell, F; Rovira, RE; Torregrosa, E, 2004) |
| "To evaluate gastrointestinal (GI) perforation in rheumatoid arthritis (RA) patients receiving tofacitinib, tocilizumab, or other biologic agents." | 7.83 | Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments. ( Bernatsky, S; Curtis, JR; Xie, F; Yun, H, 2016) |
| " The patient had initiated treatment with oral pantoprazole 40 mg/d for gastroesophageal reflux 2 months prior to admission." | 7.72 | Acute interstitial nephritis due to pantoprazole. ( Ra, A; Tobe, SW, 2004) |
| "Asthma, esophageal reflux symptoms, and spirometry were measured during baseline, placebo, and prednisone phases, each 7 days in duration." | 5.10 | Oral corticosteroids increase esophageal acid contact times in patients with stable asthma. ( Bradley, LA; Guzzo, MR; Harding, SM; Johnson, LF; Lazenby, JP; Patterson, PE, 2002) |
| " Omeprazole is a drug widely used in the treatment of gastroesophageal reflux disease and peptic ulcer disease." | 4.82 | [Acute interstitial nephritis associated with omeprazole therapy]. ( Calvo, C; García, H; Hernández-Jaras, J; Maduell, F; Rovira, RE; Torregrosa, E, 2004) |
| "To evaluate gastrointestinal (GI) perforation in rheumatoid arthritis (RA) patients receiving tofacitinib, tocilizumab, or other biologic agents." | 3.83 | Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments. ( Bernatsky, S; Curtis, JR; Xie, F; Yun, H, 2016) |
| " The patient had initiated treatment with oral pantoprazole 40 mg/d for gastroesophageal reflux 2 months prior to admission." | 3.72 | Acute interstitial nephritis due to pantoprazole. ( Ra, A; Tobe, SW, 2004) |
| "Esophageal eosinophilia and eosinophilic esophagitis (EoE) are increasingly recognized and prevalent conditions, which now represent common clinical problems encountered by gastroenterologists, pathologists, and allergists." | 1.39 | ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). ( Dellon, ES; Furuta, GT; Gonsalves, N; Hirano, I; Katzka, DA; Liacouras, CA, 2013) |
| "In refractory cases of GERD, eosinophilic esophagitis must be considered before any surgical measure." | 1.32 | Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children--discussion on daily practice. ( Cury, EK; Faintuch, S; Schraibman, V, 2004) |
| "Epidermolysis bullosa is a rare hereditary mechanobullous skin disorder." | 1.27 | Esophageal involvement in epidermolysis bullosa dystrophica: clinical and roentgenographic manifestations. ( Agha, FP; Ellis, CN; Francis, IR, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dellon, ES | 1 |
| Gonsalves, N | 1 |
| Hirano, I | 1 |
| Furuta, GT | 1 |
| Liacouras, CA | 1 |
| Katzka, DA | 1 |
| Tobin, E | 1 |
| Pokharel, S | 1 |
| Haqqie, S | 1 |
| Asif, A | 1 |
| Xie, F | 1 |
| Yun, H | 1 |
| Bernatsky, S | 1 |
| Curtis, JR | 1 |
| Rothenberg, S | 1 |
| Cowles, R | 1 |
| Payne, DN | 1 |
| Adcocz, JM | 1 |
| Füessl, HS | 1 |
| Ra, A | 1 |
| Tobe, SW | 1 |
| Cury, EK | 1 |
| Schraibman, V | 1 |
| Faintuch, S | 1 |
| Kaplan, M | 1 |
| Mutlu, EA | 1 |
| Jakate, S | 1 |
| Bruninga, K | 1 |
| Losurdo, J | 2 |
| Keshavarzian, A | 1 |
| Torregrosa, E | 1 |
| Rovira, RE | 1 |
| Calvo, C | 1 |
| Hernández-Jaras, J | 1 |
| Maduell, F | 1 |
| García, H | 1 |
| Agha, FP | 1 |
| Francis, IR | 1 |
| Ellis, CN | 1 |
| Helling, TS | 1 |
| Lazenby, JP | 1 |
| Guzzo, MR | 1 |
| Harding, SM | 1 |
| Patterson, PE | 1 |
| Johnson, LF | 1 |
| Bradley, LA | 1 |
| Field, SK | 1 |
| Ramirez-Mata, M | 1 |
| Reyes, PA | 1 |
| Alarcon-Segovia, D | 1 |
| Garza, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)[NCT04149470] | Phase 4 | 90 participants (Anticipated) | Interventional | 2020-10-07 | Recruiting | ||
| Randomized Controlled Trial Comparing Fluticasone Plus Omeprazole With Fluticasone Alone for Eosinophilic Esophagitis[NCT03781596] | Phase 4 | 100 participants (Anticipated) | Interventional | 2018-10-02 | Recruiting | ||
| Safety and Feasibility of Oral Food Desensitization in Children With Eosinophilic Esophagitis[NCT02881372] | 5 participants (Anticipated) | Interventional | 2018-08-08 | Recruiting | |||
| A Pilot Study Assessing the Efficacy of Short Duration Six Food Elimination Diet in Eosinophilic Esophagitis (EoE)[NCT03354221] | 0 participants (Actual) | Interventional | 2017-08-31 | Withdrawn (stopped due to Change in literature to suggest at least 6 weeks of initial elimination is necessary to see decrease in eosinophil count.) | |||
| Plasma and Urine Metabolomics for Biomarker Discovery in Children With Eosinophilic Esophagitis[NCT03107819] | 24 participants (Actual) | Observational | 2017-03-29 | Completed | |||
| Pilot Study of EsoCheck Compared to Biopsies and Brush Cytology During Endoscopy for Evaluation of Eosinophilic Esophagitis.[NCT04311970] | 12 participants (Actual) | Interventional | 2020-08-05 | Completed | |||
| A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis[NCT03657771] | 22 participants (Actual) | Interventional | 2018-11-12 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisone and Gastroesophageal Reflux
| Article | Year |
|---|---|
[Acute interstitial nephritis associated with omeprazole therapy].
Topics: Acute Disease; Aged; Combined Modality Therapy; Enzyme Inhibitors; Female; Gastroesophageal Reflux; | 2004 |
1 trial available for prednisone and Gastroesophageal Reflux
| Article | Year |
|---|---|
Oral corticosteroids increase esophageal acid contact times in patients with stable asthma.
Topics: Adult; Asthma; Cross-Over Studies; Esophagus; Female; Gastric Acid; Gastroesophageal Reflux; Humans; | 2002 |
13 other studies available for prednisone and Gastroesophageal Reflux
| Article | Year |
|---|---|
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Topics: Adult; Algorithms; Androstadienes; Anti-Inflammatory Agents; Biopsy; Clinical Trials as Topic; Diagn | 2013 |
Quiz Page March 2016: A 60-Year-Old Man With Fever, Night Sweats, and Acute Kidney Injury.
Topics: Biopsy; Creatinine; Diagnosis, Differential; Gastroesophageal Reflux; Glucocorticoids; Humans; Kidne | 2016 |
Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments.
Topics: Abatacept; Adult; Age Factors; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthri | 2016 |
The effects of laparoscopic Nissen fundoplication on patients with severe gastroesophageal reflux disease and steroid-dependent asthma.
Topics: Adolescent; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Fe | 2012 |
Case 2: presentation. Poor response to asthma treatment.
Topics: Administration, Oral; Adolescent; Anti-Asthmatic Agents; Asthma; Diagnosis, Differential; Female; Fo | 2001 |
[Heartburn without esophagitis. Symptoms more important than the finding?].
Topics: Androstadienes; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ul | 2003 |
Acute interstitial nephritis due to pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Aged; Benzimidazoles; | 2004 |
Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children--discussion on daily practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biopsy; Child; Cimetidine; Diagnosis, Differential; Enzyme | 2004 |
Endoscopy in eosinophilic esophagitis: "feline" esophagus and perforation risk.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biomarkers; Biopsy; Budesonide; Catheterization; Degl | 2003 |
Esophageal involvement in epidermolysis bullosa dystrophica: clinical and roentgenographic manifestations.
Topics: Adolescent; Adult; Cicatrix; Deglutition Disorders; Dilatation; Epidermolysis Bullosa; Esophageal Di | 1983 |
Perforation of the stomach during laparoscopic Nissen fundoplication in a patient on chronic corticosteroid therapy.
Topics: Adult; Azathioprine; Female; Fundoplication; Gastroesophageal Reflux; Glucocorticoids; Humans; Immun | 1995 |
Asthma and gastroesophageal reflux: another piece in the puzzle?
Topics: Adult; Airway Resistance; Asthma; Esophagogastric Junction; Female; Gastroesophageal Reflux; Humans; | 2002 |
Esophageal motility in systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Aspirin; Azathioprine; Chloroquine; Deglutition Disorders; Dilatation; Drug | 1974 |